Analysts remain upbeat on Bursa Malaysia Bhd's prospects, given its aim of reframing its initial public offering (IPO) cycle towards quality stocks.
The IPO class of 2026 is likely to receive its first incumbent, after Aktis Oncology set its sights on a public listing that could see proceeds of around $210m. The cancer treatment-focused biotech ...
Kraken’s pending IPO and the wave of crypto companies seeking public listings may help the industry attract more TradFi capital. A potential initial public offering (IPO) next year by cryptocurrency ...
After euphoric listings and sharp corrections, can India’s IPO market recalibrate valuations, protect retail capital, and regain credibility in early 2026 The Indian IPO market over the past 15 months ...
Every cycle has that one moment that splits winners from watchers. That’s the moment a project stops being “one to monitor” and becomes the one people wish ...
The recent IPO boom signals confidence in India’s economic story, but confidence should not slide into complacency India’s IPO market has delivered eye-catching numbers over the past two years, with ...
As the global business community converges at Davos, we are seeing powerful catalysts driving M&A and capital markets activity. The foundational drivers that accelerated business activity in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results